In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia

Kevin P. Battaile, Raynard L. Bateman, Derik Mortimer, Jean Mulcahy, R. Keaney Rathbun, Grover Bagby, William Fleming, Markus Grompe

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Fanconi anemia (FA) is an autosomal recessive disorder characterized by birth defects, increased incidence of malignancy, and progressive bone marrow failure. Bone marrow transplantation is therapeutic and, therefore, FA is a candidate disease for hematopoietic gene therapy. The frequent finding of somatic mosaicism in blood of FA patients has raised the question of whether wild-type bone marrow may have a selective growth advantage. To test this hypothesis, a cohort radio-ablated wild-type mice were transplanted with a 1:1 mixture of FA group C knockout (FACKO) and wild-type bone marrow. Analysis of peripheral blood at 1 month posttransplantation showed only a moderate advantage for wild-type cells, but upon serial transplantation, clear selection was observed. Next, a cohort of FACKO mice received a transplant of wild-type marrow cells without prior radioablation. No wild- type cells were detected in peripheral blood after transplantation, but a single injection of mitomycin C (MMC) resulted in an increase to greater than 25% of wild-type DNA. Serial transplantation showed that the selection occurred at the level of hematopoietic stem cells. No systemic side effects were observed. Our results show that in vivo selection for wild-type hematopoietic stem cells occurs in FA and that it is enhanced by MMC administration.

Original languageEnglish (US)
Pages (from-to)2151-2158
Number of pages8
JournalBlood
Volume94
Issue number6
StatePublished - Sep 15 1999
Externally publishedYes

Fingerprint

Fanconi Anemia
Hematopoietic Stem Cells
Stem cells
Bone
Bone Marrow
Blood
Mitomycin
Transplantation
Gene therapy
Transplants
Mosaicism
Bone Marrow Transplantation
Radio
Knockout Mice
Genetic Therapy
Cells
Defects
DNA
Injections
Incidence

ASJC Scopus subject areas

  • Hematology

Cite this

Battaile, K. P., Bateman, R. L., Mortimer, D., Mulcahy, J., Rathbun, R. K., Bagby, G., ... Grompe, M. (1999). In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. Blood, 94(6), 2151-2158.

In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. / Battaile, Kevin P.; Bateman, Raynard L.; Mortimer, Derik; Mulcahy, Jean; Rathbun, R. Keaney; Bagby, Grover; Fleming, William; Grompe, Markus.

In: Blood, Vol. 94, No. 6, 15.09.1999, p. 2151-2158.

Research output: Contribution to journalArticle

Battaile, KP, Bateman, RL, Mortimer, D, Mulcahy, J, Rathbun, RK, Bagby, G, Fleming, W & Grompe, M 1999, 'In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia', Blood, vol. 94, no. 6, pp. 2151-2158.
Battaile KP, Bateman RL, Mortimer D, Mulcahy J, Rathbun RK, Bagby G et al. In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. Blood. 1999 Sep 15;94(6):2151-2158.
Battaile, Kevin P. ; Bateman, Raynard L. ; Mortimer, Derik ; Mulcahy, Jean ; Rathbun, R. Keaney ; Bagby, Grover ; Fleming, William ; Grompe, Markus. / In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. In: Blood. 1999 ; Vol. 94, No. 6. pp. 2151-2158.
@article{65fdd3bc361d43fe940c9c3c52bc074b,
title = "In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia",
abstract = "Fanconi anemia (FA) is an autosomal recessive disorder characterized by birth defects, increased incidence of malignancy, and progressive bone marrow failure. Bone marrow transplantation is therapeutic and, therefore, FA is a candidate disease for hematopoietic gene therapy. The frequent finding of somatic mosaicism in blood of FA patients has raised the question of whether wild-type bone marrow may have a selective growth advantage. To test this hypothesis, a cohort radio-ablated wild-type mice were transplanted with a 1:1 mixture of FA group C knockout (FACKO) and wild-type bone marrow. Analysis of peripheral blood at 1 month posttransplantation showed only a moderate advantage for wild-type cells, but upon serial transplantation, clear selection was observed. Next, a cohort of FACKO mice received a transplant of wild-type marrow cells without prior radioablation. No wild- type cells were detected in peripheral blood after transplantation, but a single injection of mitomycin C (MMC) resulted in an increase to greater than 25{\%} of wild-type DNA. Serial transplantation showed that the selection occurred at the level of hematopoietic stem cells. No systemic side effects were observed. Our results show that in vivo selection for wild-type hematopoietic stem cells occurs in FA and that it is enhanced by MMC administration.",
author = "Battaile, {Kevin P.} and Bateman, {Raynard L.} and Derik Mortimer and Jean Mulcahy and Rathbun, {R. Keaney} and Grover Bagby and William Fleming and Markus Grompe",
year = "1999",
month = "9",
day = "15",
language = "English (US)",
volume = "94",
pages = "2151--2158",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia

AU - Battaile, Kevin P.

AU - Bateman, Raynard L.

AU - Mortimer, Derik

AU - Mulcahy, Jean

AU - Rathbun, R. Keaney

AU - Bagby, Grover

AU - Fleming, William

AU - Grompe, Markus

PY - 1999/9/15

Y1 - 1999/9/15

N2 - Fanconi anemia (FA) is an autosomal recessive disorder characterized by birth defects, increased incidence of malignancy, and progressive bone marrow failure. Bone marrow transplantation is therapeutic and, therefore, FA is a candidate disease for hematopoietic gene therapy. The frequent finding of somatic mosaicism in blood of FA patients has raised the question of whether wild-type bone marrow may have a selective growth advantage. To test this hypothesis, a cohort radio-ablated wild-type mice were transplanted with a 1:1 mixture of FA group C knockout (FACKO) and wild-type bone marrow. Analysis of peripheral blood at 1 month posttransplantation showed only a moderate advantage for wild-type cells, but upon serial transplantation, clear selection was observed. Next, a cohort of FACKO mice received a transplant of wild-type marrow cells without prior radioablation. No wild- type cells were detected in peripheral blood after transplantation, but a single injection of mitomycin C (MMC) resulted in an increase to greater than 25% of wild-type DNA. Serial transplantation showed that the selection occurred at the level of hematopoietic stem cells. No systemic side effects were observed. Our results show that in vivo selection for wild-type hematopoietic stem cells occurs in FA and that it is enhanced by MMC administration.

AB - Fanconi anemia (FA) is an autosomal recessive disorder characterized by birth defects, increased incidence of malignancy, and progressive bone marrow failure. Bone marrow transplantation is therapeutic and, therefore, FA is a candidate disease for hematopoietic gene therapy. The frequent finding of somatic mosaicism in blood of FA patients has raised the question of whether wild-type bone marrow may have a selective growth advantage. To test this hypothesis, a cohort radio-ablated wild-type mice were transplanted with a 1:1 mixture of FA group C knockout (FACKO) and wild-type bone marrow. Analysis of peripheral blood at 1 month posttransplantation showed only a moderate advantage for wild-type cells, but upon serial transplantation, clear selection was observed. Next, a cohort of FACKO mice received a transplant of wild-type marrow cells without prior radioablation. No wild- type cells were detected in peripheral blood after transplantation, but a single injection of mitomycin C (MMC) resulted in an increase to greater than 25% of wild-type DNA. Serial transplantation showed that the selection occurred at the level of hematopoietic stem cells. No systemic side effects were observed. Our results show that in vivo selection for wild-type hematopoietic stem cells occurs in FA and that it is enhanced by MMC administration.

UR - http://www.scopus.com/inward/record.url?scp=0033567909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033567909&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 2151

EP - 2158

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -